These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2038352)

  • 1. [Intestinal excretion of nystatin during and after oral administration to newborn infants at risk].
    Blaschke-Hellmessen R; Pannwitz U; Schwarze R
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):89-91. PubMed ID: 2038352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mycologic monitoring of newborn infants at risk during preventive administration of nystatin].
    Blaschke-Hellmessen R; Schwarze R
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):92-5. PubMed ID: 2038353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with an antimycotic foam preparation with added prednisolone (Nystacorton foam)].
    Pillwein K; Rauschmeier W; Berger H
    Padiatr Padol; 1986; 21(1):75-80. PubMed ID: 3960566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Soor prevention in premature infants. I. Effectiveness of nystatin in healthy newborn infants].
    Schwarze R; Blaschke-Hellmessen R; Hinkel GK; Hoffmann H; Weigl I
    Kinderarztl Prax; 1976 Jul; 44(7):305-14. PubMed ID: 966457
    [No Abstract]   [Full Text] [Related]  

  • 5. [Congenital candida infections].
    Schlösser RL; Zubcov A; Bollinger M; Kühnert M; Loewenich V
    Monatsschr Kinderheilkd; 1993 Nov; 141(11):864-7. PubMed ID: 8283992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants.
    Goins RA; Ascher D; Waecker N; Arnold J; Moorefield E
    Pediatr Infect Dis J; 2002 Dec; 21(12):1165-7. PubMed ID: 12506950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amphotericin B level in feces and serum during oral administration in newborns at risk].
    Blaschke-Hellmessen R; Schwarze R
    Mycoses; 1994; 37 Suppl 1():84-8. PubMed ID: 7854372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal.
    Hoppe JE
    Pediatr Infect Dis J; 1997 Sep; 16(9):885-94. PubMed ID: 9306485
    [No Abstract]   [Full Text] [Related]  

  • 9. [The occurrence of nappy rash at a children's hospital and its treatment with Canesten (author's transl)].
    Kellerer K; Grubbauer HM
    Wien Klin Wochenschr; 1978 Jan; 90(1):13-6. PubMed ID: 625982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diaper rash].
    Weitgasser H
    Dtsch Med Wochenschr; 1972 Feb; 97(8):309. PubMed ID: 5058439
    [No Abstract]   [Full Text] [Related]  

  • 11. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents.
    Ohnemus U; Willers C; Bubenheim M; Horstkotte MA; Houdek P; Fischer F; Schmage P; Moll I; Brandner JM
    Mycoses; 2008 Jan; 51(1):21-9. PubMed ID: 18076591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perianal candidosis--a comparative study with mupirocin and nystatin.
    de Wet PM; Rode H; van Dyk A; Millar AJ
    Int J Dermatol; 1999 Aug; 38(8):618-22. PubMed ID: 10487455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination.
    de Aguiar MM; de Albuquerque RP; Marinho DS; Braga BR; Dornelas CB; Oliveira A; de Sousa VP; Torres SR; Alviano DS; Alviano CS; Cabral LM; Holandino C
    Drug Dev Ind Pharm; 2010 May; 36(5):594-600. PubMed ID: 19954405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital Cutaneous Candidiasis: Prompt Systemic Treatment Is Associated With Improved Outcomes in Neonates.
    Kaufman DA; Coggins SA; Zanelli SA; Weitkamp JH
    Clin Infect Dis; 2017 May; 64(10):1387-1395. PubMed ID: 28158439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioassay for determination of nystatin in faeces after oral application.
    Blaschke-Hellmessen R; Schwarze U
    Mycoses; 1990 Mar; 33(3):129-35. PubMed ID: 2113608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of candidal diaper dermatitis: a double-blind placebo-controlled comparison of topical nystatin with topical plus oral nystatin.
    Munz D; Powell KR; Pai CH
    J Pediatr; 1982 Dec; 101(6):1022-5. PubMed ID: 6754898
    [No Abstract]   [Full Text] [Related]  

  • 17. Concentrations of nystatin in faeces after oral administration of various doses of nystatin.
    Hofstra W; de Vries-Hospers HG; van der Waaij D
    Infection; 1979; 7(4):166-70. PubMed ID: 511333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective comparison of miconazole gel and nystatin suspension in the treatment of oral candidiasis].
    Schaad UB; Bachmann D
    Schweiz Med Wochenschr; 1983 Sep; 113(38):1356-62. PubMed ID: 6356343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrush incidence in newborns and infants].
    Simon C; Klose-Gerlich FT
    Med Welt; 1969 Sep; 64(38):2062-4. PubMed ID: 5390895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.